245 related articles for article (PubMed ID: 32988380)
1. Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension.
Yiangou A; Mitchell JL; Vijay V; Grech O; Bilton E; Lavery GG; Fisher C; Edwards J; Mollan SP; Sinclair AJ
J Headache Pain; 2020 Sep; 21(1):116. PubMed ID: 32988380
[TBL] [Abstract][Full Text] [Related]
2. Erenumab for headaches in idiopathic intracranial hypertension: A prospective open-label evaluation.
Yiangou A; Mitchell JL; Fisher C; Edwards J; Vijay V; Alimajstorovic Z; Grech O; Lavery GG; Mollan SP; Sinclair AJ
Headache; 2021 Jan; 61(1):157-169. PubMed ID: 33316102
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin gene-related peptide (CGRP) levels in peripheral blood in patients with idiopathic intracranial hypertension and migraine.
Ak AK; Gemici YI; Batum M; Karakaş B; Özmen EY; Gökçay F; Çelebisoy N
Clin Neurol Neurosurg; 2024 Feb; 237():108136. PubMed ID: 38308939
[TBL] [Abstract][Full Text] [Related]
4. Plasma calcitonin gene-related peptide levels in idiopathic intracranial hypertension: an exploratory study.
Krajnc N; Frank F; Macher S; Michl M; Müller N; Maier S; Zaic S; Wöber C; Pemp B; Broessner G; Bsteh G
J Headache Pain; 2024 Jun; 25(1):92. PubMed ID: 38834953
[TBL] [Abstract][Full Text] [Related]
5. Headache attributed to idiopathic intracranial hypertension and persistent post-idiopathic intracranial hypertension headache: A narrative review.
Mollan SP; Grech O; Sinclair AJ
Headache; 2021 Jun; 61(6):808-816. PubMed ID: 34106464
[TBL] [Abstract][Full Text] [Related]
6. Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension.
Mollan SP; Wakerley BR; Alimajstorovic Z; Mitchell J; Ottridge R; Yiangou A; Thaller M; Gupta A; Grech O; Lavery G; Brock K; Sinclair AJ
J Headache Pain; 2021 Oct; 22(1):118. PubMed ID: 34620087
[TBL] [Abstract][Full Text] [Related]
7. Headache in idiopathic intracranial hypertension. A CGRP-dependent head pain?
De Simone R; Sansone M; Bonavita V
Neurol Sci; 2020 Dec; 41(Suppl 2):417-421. PubMed ID: 32852682
[TBL] [Abstract][Full Text] [Related]
8. High-pressure headaches: idiopathic intracranial hypertension and its mimics.
Peng KP; Fuh JL; Wang SJ
Nat Rev Neurol; 2012 Dec; 8(12):700-10. PubMed ID: 23165338
[TBL] [Abstract][Full Text] [Related]
9. Advances in the understanding of headache in idiopathic intracranial hypertension.
Mollan SP; Hoffmann J; Sinclair AJ
Curr Opin Neurol; 2019 Feb; 32(1):92-98. PubMed ID: 30547900
[TBL] [Abstract][Full Text] [Related]
10. Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol.
Ottridge R; Mollan SP; Botfield H; Frew E; Ives NJ; Matthews T; Mitchell J; Rick C; Singhal R; Woolley R; Sinclair AJ
BMJ Open; 2017 Sep; 7(9):e017426. PubMed ID: 28963303
[TBL] [Abstract][Full Text] [Related]
11. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
Tepper SJ
Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
[TBL] [Abstract][Full Text] [Related]
12. Intracranial pressure in patients with papilloedema.
Funnell JP; Craven CL; D'Antona L; Thompson SD; Chari A; Thorne L; Watkins LD; Toma AK
Acta Neurol Scand; 2018 Aug; 138(2):137-142. PubMed ID: 29532475
[TBL] [Abstract][Full Text] [Related]
13. Cluster-like headache and idiopathic intracranial hypertension: a case report.
Testa L; Mittino D; Terazzi E; Mula M; Monaco F
J Headache Pain; 2008 Jun; 9(3):181-3. PubMed ID: 18418548
[TBL] [Abstract][Full Text] [Related]
14. Incidence and predictors of dural venous sinus pressure gradient in idiopathic intracranial hypertension and non-idiopathic intracranial hypertension headache patients: results from 164 cerebral venograms.
Levitt MR; Hlubek RJ; Moon K; Kalani MY; Nakaji P; Smith KA; Little AS; Knievel K; Chan JW; McDougall CG; Albuquerque FC
J Neurosurg; 2017 Feb; 126(2):347-353. PubMed ID: 26967777
[TBL] [Abstract][Full Text] [Related]
15. Headache, Opiate Use, and Prescribing Trends in Women With Idiopathic Intracranial Hypertension: A Population-Based Matched Cohort Study.
Adderley NJ; Subramanian A; Perrins M; Nirantharakumar K; Mollan SP; Sinclair AJ
Neurology; 2022 Oct; 99(18):e1968-e1978. PubMed ID: 35985824
[TBL] [Abstract][Full Text] [Related]
16. Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018.
Tepper SJ
Headache; 2018 Nov; 58 Suppl 3():276-290. PubMed ID: 30403405
[TBL] [Abstract][Full Text] [Related]
17. Headache prevalence and clinical features in patients with idiopathic intracranial hypertension (IIH).
D Amico D; Curone M; Ciasca P; Cammarata G; Melzi L; Bussone G; Bianchi Marzoli S
Neurol Sci; 2013 May; 34 Suppl 1():S147-9. PubMed ID: 23695067
[TBL] [Abstract][Full Text] [Related]
18. Headache diagnoses in patients with treated idiopathic intracranial hypertension.
Friedman DI; Rausch EA
Neurology; 2002 May; 58(10):1551-3. PubMed ID: 12034799
[TBL] [Abstract][Full Text] [Related]
19. Migraine induction with calcitonin gene-related peptide in patients from erenumab trials.
Christensen CE; Younis S; Deen M; Khan S; Ghanizada H; Ashina M
J Headache Pain; 2018 Nov; 19(1):105. PubMed ID: 30409109
[TBL] [Abstract][Full Text] [Related]
20. Case series of six patients diagnosed and managed for idiopathic intracranial hypertension at a tertiary institution eye centre.
Tagoe NN; Beyuo VM; Amissah-Arthur KN
Ghana Med J; 2019 Mar; 53(1):79-87. PubMed ID: 31138948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
